iBio (IBIO) Current Leases (2016 - 2025)
iBio (IBIO) recorded Current Leases of $53,000 in fiscal Q4 2025 (quarter ended Jun 30, 2025), down 82.3% from $299,000 a year earlier and down 59.2% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Current Leases (2016 - 2025) Analysis & Trends
Starting with fiscal Q3 2016, iBio's Current Leases history includes 38 quarters.
- Annual Current Leases has a five-year compound annual growth rate of -29.3% (FY2020 to FY2025).
- Across earlier fiscal years, Current Leases came in at $299,000 in FY2024 (+9.9%), $272,000 in FY2023 (+491.3%), $46,000 in FY2022 (-87.5%) and $367,000 in FY2021 (+21.9%).
- The fiscal Q4 2025 figure is the lowest quarterly Current Leases since fiscal Q4 2022.
- On a year-over-year basis, Current Leases has declined for four consecutive quarters, with an average decline of 18.0% over the last eight quarters.
- Peak year-over-year performance for Current Leases in the last five years was growth of 491.3% in fiscal Q4 2023, against a decline of 87.5% in fiscal Q4 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $130,000 (Q3 2025), $205,000 (Q2 2025) and $279,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | iBio | 121.75 Mn | 121.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 279,000.00 |
| Jun 30, 2024 | 299,000.00 |
| Mar 31, 2024 | 292,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 272,000.00 |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | 259,000.00 |
| Sep 30, 2022 | 303,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 374,000.00 |
| Jun 30, 2021 | 367,000.00 |
| Mar 31, 2021 | 318,000.00 |
| Dec 31, 2020 | 312,000.00 |
| Sep 30, 2020 | 306,000.00 |
API Access
iBio Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();